RETRACTED ARTICLE: Utero-placental perfusion Doppler indices in growth restricted fetuses: effect of sildenafil citrate
Authors:
- 27 March 2017
- journal article
- retracted article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 31 (8) , 1045-1050
Abstract
To assess efficacy and tolerability of sildenafil citrate on utero-placental blood flow and fetal growth in pregnancies complicated by fetal growth restriction (FGR). From March 2015, a randomized controlled trial of 54 patients at 24 weeks or more complicated by FGR and abnormal Doppler indices were randomly allocated 1:1 into an intervention arm (receive sildenafil citrate, 50 mg) or a control arm (receive placebo). The primary outcomes were changes occurred in the Doppler parameters 2 h following drug administration. Baseline characteristics were similar between groups. Significant difference was observed in the Delta uterine and umbilical Doppler indices among sildenafil group as compared to placebo group (p < 0.001). Middle cerebral Doppler indices, however, decreased significantly after sildenafil, which could be the result of shifting more blood to improve the utero-placental perfusion. No difference regarding Delta cerebro-placental ratio among both groups (p = 0.979). Sildenafil was also associated with pregnancy prolongation (p = .0001), increased gestational age at delivery (p = .004), improved neonatal weight (p = .0001), and less admission to neonatal intensive care unit (p = .03). No adverse effects reported in both treatment arms. Sildenafil citrate, by its vasodilator effect, can improve utero-placental blood flow in pregnancies complicated by FGR and abnormal Doppler. gov Registry: NCT02362399.Keywords
This publication has 17 references indexed in Scilit:
- Maternal Administration of Sildenafil Citrate Alters Fetal and Placental Growth and Fetal–Placental Vascular Resistance in the Growth-Restricted Ovine FetusHypertension, 2016
- Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular PhenotypePLOS ONE, 2013
- ISUOG Practice Guidelines: use of Doppler ultrasonography in obstetricsUltrasound in Obstetrics & Gynecology, 2013
- Early onset, severe fetal growth restriction with absent or reversed end‐diastolic flow velocity waveform in the umbilical artery: Perinatal and long‐term outcomesAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2009
- Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestationUltrasound in Obstetrics & Gynecology, 2008
- Cerebroplacental Doppler Ratio and Adverse Perinatal Outcomes in Intrauterine Growth RestrictionJournal of Ultrasound in Medicine, 2005
- Sildenafil Citrate (Viagra) Enhances Vasodilatation in Fetal Growth RestrictionThe Journal of Clinical Endocrinology & Metabolism, 2005
- Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Effects of combined use of sildenafil citrate (Viagra) and 17β-estradiol on ovine coronary and uterine hemodynamicsAmerican Journal of Obstetrics and Gynecology, 2004
- Blood flow velocity waveforms of the fetal middle cerebral artery in a normal population: reference values from 18 weeks to 42 weeks of gestationJournal of Perinatal Medicine, 2002